DexCom, Inc. (DXCM)

73.93 +1.82 (+2.52%) USD  |  NASDAQ  |  Jan 22, 16:00
74.23 +0.30 (+0.41%) After-Hours: 20:00
More

DexCom Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Abbott Laboratories Upgrade
BioLife Solutions, Inc. Upgrade
Boston Scientific Corp. Upgrade
Krystal Biotech, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade